Cargando…
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
Of more than 150,000 published studies evaluating new biomarkers, fewer than 100 biomarkers have been implemented for patient care[1]. One reason for this is lack of rigorous testing by the medical community to validate claims for biomarker clinical relevance, and potential reluctance to publish neg...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107197/ https://www.ncbi.nlm.nih.gov/pubmed/24434899 http://dx.doi.org/10.1038/modpathol.2013.226 |